Javier Bolaños-Meade

Javier Bolaños-Meade

UNVERIFIED PROFILE

Are you Javier Bolaños-Meade?   Register this Author

Register author
Javier Bolaños-Meade

Javier Bolaños-Meade

Publications by authors named "Javier Bolaños-Meade"

Are you Javier Bolaños-Meade?   Register this Author

97Publications

2422Reads

49Profile Views

Allogeneic Haploidentical Blood or Marrow Transplantation with Post-Transplant Cyclophosphamide in Chronic Lymphocytic Leukemia.

Biol Blood Marrow Transplant 2019 Nov 12. Epub 2019 Nov 12.

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2019.11.008DOI Listing
November 2019

Impact of cytogenetic abnormalities on outcomes of adult Philadelphia-negative acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation: a study by the Acute Leukemia Working Committee of the Center for International Blood and Marrow Transplant Research.

Haematologica 2019 09 26. Epub 2019 Sep 26.

Department of Medicine, University of Minnesota Medical Center, Minneapolis, MN, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.2019.220756DOI Listing
September 2019

Effect of increased dose of total body irradiation on graft failure associated with HLA-haploidentical transplantation in patients with severe haemoglobinopathies: a prospective clinical trial.

Lancet Haematol 2019 Apr 14;6(4):e183-e193. Epub 2019 Mar 14.

Hematologic Malignancies and Bone Marrow Transplantation Program, Department of Oncology, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Johns Hopkins University School of Medicine, Baltimore, MD, USA; Division of Hematology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2352-3026(19)30031-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6506220PMC
April 2019

Major Histocompatibility Mismatch and Donor Choice for Second Allogeneic Bone Marrow Transplantation.

Biol Blood Marrow Transplant 2017 Nov 25;23(11):1887-1894. Epub 2017 Jul 25.

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Division of Hematologic Malignancies, Bunting Blaustein Cancer Research Bldg., 1650 Orleans Street, Baltimore, Maryland. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2017.07.014DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5881910PMC
November 2017

Post-Transplantation Cyclophosphamide after Bone Marrow Transplantation Is Not Associated with an Increased Risk of Donor-Derived Malignancy.

Biol Blood Marrow Transplant 2017 Apr 3;23(4):612-617. Epub 2017 Jan 3.

Blood and Marrow Transplantation Program, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins Hospital, Baltimore, Maryland. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2016.12.640DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5632950PMC
April 2017

Reduced-Intensity Transplantation for Lymphomas Using Haploidentical Related Donors Versus HLA-Matched Sibling Donors: A Center for International Blood and Marrow Transplant Research Analysis.

J Clin Oncol 2016 09 6;34(26):3141-9. Epub 2016 Jun 6.

Nilanjan Ghosh, Levine Cancer Institute, Carolinas Healthcare System, Charlotte, NC; Reem Karmali, Rush University Medical Center; Sonali M. Smith, The University of Chicago, Chicago, IL; Vanderson Rocha, Churchill Hospital, Oxford, United Kingdom; Kwang Woo Ahn, Alyssa DiGilio, and Mehdi Hamadani, Medical College of Wisconsin & Center for International Blood and Marrow Transplant Research; Parameswaran N. Hari and Anita D'Souza, Medical College of Wisconsin; Timothy S. Fenske, Froedtert Memorial Lutheran Hospital, Milwaukee, WI; Veronika Bachanova, University of Minnesota Medical Center, Minneapolis, MN; Ulrike Bacher, University Medicine Goettingen and University Cancer Center Hamburg, Hamburg, Germany; Parastoo Dahi, Memorial Sloan Kettering Cancer Center-Adults, New York, NY; Marcos de Lima, University Hospitals Case Medical Center, Cleveland; Samantha Jaglowski, The Ohio State University Medical Center, Columbus, OH; Siddhartha Ganguly, University of Kansas Medical Center, Kansas City, KS; Mohamed A. Kharfan-Dabaja, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL; Tim D. Prestidge, Blood and Cancer Centre, Starship Children's Hospital, Auckland, New Zealand; Bipin N. Savani, Vanderbilt University Medical Center, Nashville, TN; Anna M. Sureda, European Group for Blood and Marrow Transplantation and Hospital Duran I Reynals, Barcelona, Spain; Edmund K. Waller, Winship Cancer Institute, Emory University, Atlanta, GA; Alex F. Herrera, City of Hope National Medical Center, Duarte, CA; Philippe Armand, Dana-Farber Cancer Institute, Boston, MA; Rachel B. Salit, Fred Hutchinson Cancer Research Center, Seattle, WA; and Nina D. Wagner-Johnston, Ephraim Fuchs, and Javier Bolaños-Meade, Johns Hopkins University Sidney Kimmel Cancer Center, Baltimore, MD.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.66.3476DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5012706PMC
September 2016

Factors associated with optimized tacrolimus dosing in hematopoietic stem cell transplantation.

J Oncol Pharm Pract 2016 Apr 22;22(2):275-83. Epub 2015 Mar 22.

Department of Pharmacy, The Johns Hopkins Hospital, Baltimore, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1078155215577809DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4696901PMC
April 2016

A refined risk score for acute graft-versus-host disease that predicts response to initial therapy, survival, and transplant-related mortality.

Biol Blood Marrow Transplant 2015 Apr 10;21(4):761-7. Epub 2015 Jan 10.

Blood and Marrow Transplant Program, University of Minnesota, Minneapolis, Minnesota; Blood and Marrow Transplant Clinical Trials Network GVHD Study Committee, Milwaukee, Wisconsin; Department of Medicine, University of Minnesota, Minneapolis, Minnesota.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2015.01.001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4359643PMC
April 2015

A prognostic score for acute graft-versus-host disease based on biomarkers: a multicentre study.

Lancet Haematol 2015 Jan 23;2(1):e21-9. Epub 2014 Dec 23.

Blood & Marrow Transplant Program, University of Michigan, Ann Arbor, MI, USA; The Tisch Cancer Institute, The Icahn School of Medicine at Mount Sinai Hospital, New York, NY, USA. Electronic address:

View Article

Download full-text PDF

Source
http://www.thelancet.com/pdfs/journals/lanhae/PIIS2352-3026(
Web Search
http://linkinghub.elsevier.com/retrieve/pii/S235230261400035
Publisher Site
http://dx.doi.org/10.1016/S2352-3026(14)00035-0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4340092PMC
January 2015

Blood and marrow transplantation for sickle cell disease: is less more?

Blood Rev 2014 Nov 27;28(6):243-8. Epub 2014 Aug 27.

Johns Hopkins University School of Medicine, Baltimore, MD, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.blre.2014.08.001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4390117PMC
November 2014

HLA-haploidentical donor lymphocyte infusions for patients with relapsed hematologic malignancies after related HLA-haploidentical bone marrow transplantation.

Biol Blood Marrow Transplant 2014 Mar 1;20(3):314-8. Epub 2013 Dec 1.

The Sidney Kimmel Comprehensive Cancer Center, Department of Oncology at the Johns Hopkins University, Baltimore, Maryland. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2013.11.020DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4010132PMC
March 2014

Successful treatment of severe refractory hepatic graft-versus-host disease by cadaveric liver transplant.

Leuk Lymphoma 2013 Dec 30;54(12):2756-9. Epub 2013 Apr 30.

Department of Oncology, the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University , Baltimore, MD , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2013.788178DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4124622PMC
December 2013

Aldehyde dehydrogenase expression drives human regulatory T cell resistance to posttransplantation cyclophosphamide.

Sci Transl Med 2013 Nov;5(211):211ra157

The Sidney Kimmel Comprehensive Cancer Center and Department of Oncology, The Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1126/scitranslmed.3006960DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4155575PMC
November 2013

Sequential occurrence of a splenic marginal zone lymphoma, extranodal MALT lymphoma, and Hodgkin lymphoma.

Clin Lymphoma Myeloma Leuk 2013 Aug 5;13(4):496-8. Epub 2013 Jun 5.

Department of Oncology, the Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD 21287, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2013.04.004DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4659405PMC
August 2013

Lymphocyte phenotype during therapy for acute graft-versus-host disease: a brief report from BMT-CTN 0302.

Biol Blood Marrow Transplant 2013 Mar 12;19(3):481-5. Epub 2012 Dec 12.

Hematologic Malignancies, the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD 21231, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2012.12.003DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3653300PMC
March 2013

Graft-versus-host disease: state of the science.

Biol Blood Marrow Transplant 2013 Jan 27;19(1 Suppl):S102-8. Epub 2012 Oct 27.

Dept of Stem Cell Transplant and Cellular Therapy, Univeristy of Texas, MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 423, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2012.10.028DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4116672PMC
January 2013

HLA-haploidentical bone marrow transplantation with posttransplant cyclophosphamide expands the donor pool for patients with sickle cell disease.

Blood 2012 Nov 6;120(22):4285-91. Epub 2012 Sep 6.

Hematologic Malignancies and Bone Marrow Transplantation Program, Department of Oncology, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins and Johns Hopkins University School of Medicine, Baltimore, MD 21231-1000, USA.

View Article

Download full-text PDF

Source
http://www.bloodjournal.org/cgi/doi/10.1182/blood-2012-07-43
Publisher Site
http://dx.doi.org/10.1182/blood-2012-07-438408DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3507140PMC
November 2012

The importance of IGHV mutational status in del(11q) and del(17p) chronic lymphocytic leukemia.

Clin Lymphoma Myeloma Leuk 2012 Apr 28;12(2):132-7. Epub 2012 Jan 28.

The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD 21287, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2011.12.005DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3612932PMC
April 2012

Narrowband ultraviolet B phototherapy for the treatment of steroid-refractory and steroid-dependent acute graft-versus-host disease of the skin.

J Am Acad Dermatol 2011 Oct 25;65(4):733-738. Epub 2011 May 25.

Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, Maryland. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jaad.2010.08.006DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3653316PMC
October 2011

Acute myeloid leukaemia: optimal management and recent developments.

Drugs 2011 Aug;71(12):1537-50

Centro de Innovacin y Transferencia en Salud, Servicio de Hematologa del Centro Mdico Zambrano Hellion, Escuela de Medicina del Instituto Tecnolgico y de Estudios Superiores de Monterrey, Nuevo Len, Mexico.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2165/11593060-000000000-00000DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3676948PMC
August 2011

5-azacytidine as salvage treatment in relapsed myeloid tumors after allogeneic bone marrow transplantation.

Biol Blood Marrow Transplant 2011 May 15;17(5):754-8. Epub 2010 Oct 15.

George W. Santos Bone Marrow Transplant Service, Department of Oncology, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland 21231, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2010.10.008DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3090635PMC
May 2011

Graft-versus-host disease treatment: predictors of survival.

Biol Blood Marrow Transplant 2010 Dec 9;16(12):1693-9. Epub 2010 Jun 9.

Departments of Pediatrics and Internal Medicine, University of Michigan, 1500 E. Medical Center Drive, Ann Arbor, MI 48109-5941, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2010.05.019DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2955996PMC
December 2010

Blood and marrow transplantation for sickle cell disease: overcoming barriers to success.

Curr Opin Oncol 2009 Mar;21(2):158-61

Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA.

View Article

Download full-text PDF

Source
https://insights.ovid.com/crossref?an=00001622-200903000-000
Publisher Site
http://dx.doi.org/10.1097/CCO.0b013e328324ba04DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4581443PMC
March 2009

Chronic graft-versus-host disease.

Curr Pharm Des 2008 ;14(20):1974-86

The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins and Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2174/138161208785061373DOI Listing
October 2008

Grover's Disease after Bone Marrow Transplantation.

Biol Blood Marrow Transplant 2007 Sep;13(9):1116-7

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2007.06.002DOI Listing
September 2007

Phase II study of pentostatin in patients with corticosteroid-refractory chronic graft-versus-host disease.

J Clin Oncol 2007 Sep;25(27):4255-61

Robert H. Lurie Comprehensive Cancer Center and Division of Hematology/Oncology/Transplant, Children's Memorial Hospital, Chicago, IL, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2007.10.8456DOI Listing
September 2007

Montelukast in chronic graft-versus-host disease: a breath of fresh air?

Transplantation 2007 Mar;83(5):527-8

Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/01.tp.0000255603.47512.57DOI Listing
March 2007

Mesenchymal stem cells and organ transplantation: current status and promising future.

Transplantation 2006 May;81(10):1388-9

Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/01.tp.0000214461.47555.70DOI Listing
May 2006

Update on the management of acute graft-versus-host disease.

Curr Opin Oncol 2006 Mar;18(2):120-5

Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/01.cco.0000208783.69076.7eDOI Listing
March 2006

Lymphocytic pneumonitis as the manifestation of acute graft-versus-host disease of the lung.

Am J Hematol 2005 Jun;79(2):132-5

Blood and Marrow Transplant Program, University of Maryland Greenebaum Cancer Center, Baltimore, Maryland, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/ajh.20315
Publisher Site
http://dx.doi.org/10.1002/ajh.20315DOI Listing
June 2005

Hydroxychloroquine causes severe vacuolar myopathy in a patient with chronic graft-versus-host disease.

Am J Hematol 2005 Apr;78(4):306-9

Department of Oncology, The Johns Hopkins Hospital, Baltimore, Maryland 21287, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/ajh.20294
Publisher Site
http://dx.doi.org/10.1002/ajh.20294DOI Listing
April 2005

Pentostatin in steroid-refractory acute graft-versus-host disease.

J Clin Oncol 2005 Apr;23(12):2661-8

Division of Hematologic Malignancies, Department of Oncology, Johns Hopkins Univeristy, Baltimore, MD 21231, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2005.06.130DOI Listing
April 2005

[Comments on the article "Survival, clinical and laboratory characteristics in de novo and secondary megakaryoblastic leukemias].

Rev Invest Clin 2004 May-Jun;56(3):410-1; author reply 412

View Article

Download full-text PDF

Source
March 2005

Novel strategies for steroid-refractory acute graft-versus-host disease.

Curr Opin Hematol 2005 Jan;12(1):40-4

Department of Medicine, University of Maryland Greenebaum Cancer Center and University of Maryland School of Medicine, Baltimore, Maryland, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/01.moh.0000148763.12733.bbDOI Listing
January 2005

Acute graft-versus-host disease.

Clin Adv Hematol Oncol 2004 Oct;2(10):672-82

University of Maryland Greenebaum Cancer Center, Baltimore, MD, USA.

View Article

Download full-text PDF

Source
October 2004

Intensive therapy for aggressive lymphoma.

N Engl J Med 2004 Jul;351(1):98-100; author reply 98-100

View Article

Download full-text PDF

Source
July 2004

Tandem transplantation in multiple myeloma.

Oncology (Williston Park) 2003 Mar;17(3):389-98; discussion 398-400, 405-7

Bone Marrow Transplant Program, University of Maryland, Greenebaum Cancer Center, Blood and Marrow Transplant Program, Baltimore, Maryland, USA.

View Article

Download full-text PDF

Source
March 2003

Acute myeloid leukaemia arising from a patient with untreated essential thrombocythaemia.

Eur J Haematol 2002 Jun;68(6):397-9

Department of Internal Medicine, Division of Hematology and Oncology, Texas Tech University Health Sciences Center and Southwest Cancer Center, Lubbock, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1034/j.1600-0609.2002.02730.xDOI Listing
June 2002